These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 17403424)
61. Clinical and biophysical aspects of HELLP-syndrome. Ertan AK; Wagner S; Hendrik HJ; Tanriverdi HA; Schmidt W J Perinat Med; 2002; 30(6):483-9. PubMed ID: 12530105 [TBL] [Abstract][Full Text] [Related]
62. Exploring the relationship between preterm placental calcification and adverse maternal and fetal outcome. Chen KH; Chen LR; Lee YH Ultrasound Obstet Gynecol; 2011 Mar; 37(3):328-34. PubMed ID: 20586039 [TBL] [Abstract][Full Text] [Related]
63. Recurrent intrauterine growth restriction: characteristic placental histopathological features and association with prenatal vascular Doppler. Rotshenker-Olshinka K; Michaeli J; Srebnik N; Terlezky S; Schreiber L; Farkash R; Grisaru Granovsky S Arch Gynecol Obstet; 2019 Dec; 300(6):1583-1589. PubMed ID: 31667612 [TBL] [Abstract][Full Text] [Related]
64. Placental fibronectin staining is unaffected in pregnancies complicated by late-onset intrauterine growth restriction and small for gestational age fetuses. Fruscalzo A; Londero AP; Orsaria M; Marzinotto S; Driul L; Di Loreto C; Mariuzzi L Int J Gynaecol Obstet; 2020 Feb; 148(2):253-260. PubMed ID: 31743426 [TBL] [Abstract][Full Text] [Related]
65. Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independently of Doppler ultrasound. Messerschmidt A; Baschat A; Linduska N; Kasprian G; Brugger PC; Bauer A; Weber M; Prayer D Ultrasound Obstet Gynecol; 2011 Jun; 37(6):717-22. PubMed ID: 21105016 [TBL] [Abstract][Full Text] [Related]
66. Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up. Fruci S; Salvi S; Moresi S; Gallini F; Dell'Aquila M; Arena V; Di Stasio E; Ferrazzani S; De Carolis S; Lanzone A Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():37-42. PubMed ID: 36764034 [TBL] [Abstract][Full Text] [Related]
67. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature. Pham T; Steele J; Stayboldt C; Chan L; Benirschke K Am J Clin Pathol; 2006 Jul; 126(1):67-78. PubMed ID: 16753607 [TBL] [Abstract][Full Text] [Related]
68. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Zhong Y; Tuuli M; Odibo AO Prenat Diagn; 2010 Apr; 30(4):293-308. PubMed ID: 20166149 [TBL] [Abstract][Full Text] [Related]
69. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome. Fruscalzo A; Schmitz R; Klockenbusch W; Köhler G; Londero AP; Siwetz M; Huppertz B Histochem Cell Biol; 2012 Dec; 138(6):925-32. PubMed ID: 22847813 [TBL] [Abstract][Full Text] [Related]
70. Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital. Manocha A; Ravikumar G; Crasta J J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3939-3947. PubMed ID: 29792056 [No Abstract] [Full Text] [Related]
71. The impact of ultrasonographic placental architecture on antenatal course, labor and delivery in a low-risk primigravid population. Cooley SM; Donnelly JC; Walsh T; McMahon C; Gillan J; Geary MP J Matern Fetal Neonatal Med; 2011 Mar; 24(3):493-7. PubMed ID: 20608801 [TBL] [Abstract][Full Text] [Related]